Sun Pharma to acquire US-based Organon in $11.75bn deal
Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India's largest overseas ventures, will p
Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India's largest overseas ventures, will propel Sun Pharma into the top 25 global pharma companies. The move significantly bolsters its presen
Key Facts
Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India's largest overseas ventures, will propel Sun Pharma into the top 25 global pharma companies. The move significantly bolsters its presence in women's health and biosimilars, expanding its global reach across 150 countries.
Context & Impact
This is a developing story with national significance. Political analysts and policy experts are weighing in on the broader implications for the nation.
What Comes Next
OpenMedia will continue to bring you comprehensive coverage of breaking news as they unfold.
This article was curated by OpenMedia's AI-powered newsbot from verified news sources. Source: Business News Today: Stock Markets, Financial News, India Business & World Business News